Breaking News Instant updates and real-time market news.

IRWD

Ironwood

$11.00

1.15 (11.68%)

17:43
01/06/19
01/06
17:43
01/06/19
17:43

Ironwood appoints Michael Shetzline as Chief Medical Officer

Ironwood Pharmaceuticals has announced that Michael Shetzline will join Ironwood as chief medical officer, senior vice president and head of drug development, effective January 28, 2019. Shetzline will lead global product development for Ironwood following its planned separation into two independent, publicly-traded companies. In his role, Shetzline will focus on driving innovation designed to enhance the value of the company's existing GI assets and creating new GI product opportunities. He will report to Thomas McCourt, who will become President of Ironwood following the separation.

  • 07

    Jan

  • 18

    May

IRWD Ironwood
$11.00

1.15 (11.68%)

11/07/18
JPMS
11/07/18
DOWNGRADE
Target $11
JPMS
Underweight
Ironwood downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Eric Joseph downgraded Ironwood Pharmaceuticals to Underweight and lowered his price target for the shares to $11 from $20. The analyst cites a diminished growth outlook for Linzess following the company's Q3 results for the downgrade to Underweight.
11/07/18
11/07/18
DOWNGRADE
Target $14

Neutral
Ironwood downgraded to Neutral on disappointing Linzess updates at Credit Suisse
In a regulatory filing, Credit Suisse analyst Vamil Divan downgraded Ironwood to Neutral from Outperform given disappointing updates on key product Linzess and what he sees as limited drivers of near to mid-term upside. The analyst also lowered his price target on the shares to $14 from $22.
11/19/18
MZHO
11/19/18
NO CHANGE
Target $15
MZHO
Buy
Ironwood price target lowered to $15 from $23 at Mizuho
Mizuho analyst Irina Koffler lowered her price target for Ironwood Pharmaceuticals to $15 citing a more conservative 2019 spending outlook. The analyst, however, continues to view the stock as undervalued and reiterates a Buy rating on the name.
12/10/18
HCWC
12/10/18
NO CHANGE
Target $11.5
HCWC
Sell
Ironwood price target lowered to $11.50 from $12.50 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju lowered his price target for Ironwood Pharmaceuticals to $11.50 and reiterates a Sell rating on the shares. The company's "poor" recent financial performance is unlikely to improve in the near-term, Selvaraju tells investors in a research note. He expects Linzess pricing decreases and challenges to uptake will continue.

TODAY'S FREE FLY STORIES

LMFA

LM Funding

$2.19

0.765 (53.87%)

12:27
01/17/19
01/17
12:27
01/17/19
12:27
Hot Stocks
LM Funding spikes 53% after completing IIU acquisition, sees accretion in 2019 »

Earlier on Thursday, LM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWSA

News Corp.

$12.42

0.03 (0.24%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Upgrade
News Corp. rating change  »

News Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$22.17

0.9 (4.23%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Options
First Data call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BLK

BlackRock

$410.20

-2.65 (-0.64%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Periodicals
BlackRock CEO calls on business leaders to tackle social issues, FT says »

BlackRock CEO Larry Fink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 11

    Feb

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

, AAPL

Apple

$154.13

-0.75 (-0.48%)

12:22
01/17/19
01/17
12:22
01/17/19
12:22
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

AAPL

Apple

$154.13

-0.75 (-0.48%)

JNJ

Johnson & Johnson

$128.65

0.65 (0.51%)

SHLD

Sears

$0.00

(0.00%)

SBNY

Signature Bank

$120.40

7.98 (7.10%)

MTB

M&T Bank

$161.77

7.32 (4.74%)

SIG

Signet Jewelers

$25.63

-7.745 (-23.21%)

WDC

Western Digital

$35.97

-1.83 (-4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 22

    Jan

  • 24

    Jan

  • 27

    Jan

  • 29

    Jan

  • 07

    Feb

  • 18

    Feb

LPCN

Lipocine

$2.24

0.65 (40.88%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Recommendations
Lipocine analyst commentary  »

Ladenburg reiterates Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$5.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Hot Stocks
Limbach awarded contracts totaling $81.4M for hospital construction »

Limbach Holdings provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$2.27

0.68 (42.77%)

12:12
01/17/19
01/17
12:12
01/17/19
12:12
Periodicals
Lipocine NASH data contain plenty of 'red flags,' STAT's Feuerstein writes »

This morning's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVE

Cenovus Energy

$7.79

-0.19 (-2.38%)

12:10
01/17/19
01/17
12:10
01/17/19
12:10
Options
Second day of call buying in Cenovus Energy continues as shares slump »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$68.79

2.9 (4.40%)

12:04
01/17/19
01/17
12:04
01/17/19
12:04
Hot Stocks
Square launches free debit card for business, with sellers access to funds »

Square announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

ALBO

Albireo Pharma

$24.54

0.08 (0.33%)

12:03
01/17/19
01/17
12:03
01/17/19
12:03
Hot Stocks
Albireo Pharma treatment of biliary atresia granted FDA orphan status »

Albireo Pharma's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPOR

Gulfport Energy

$8.67

-0.23 (-2.58%)

12:02
01/17/19
01/17
12:02
01/17/19
12:02
Hot Stocks
Gulfport Energy confirms receipt of Firefly letter »

Gulfport Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$13.09

-2.32 (-15.06%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
United Natural Foods falls -15.1% »

United Natural Foods is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTE

Earthstone Energy

$5.28

-1.49 (-22.01%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Earthstone Energy falls -21.9% »

Earthstone Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$25.49

-7.885 (-23.63%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Signet Jewelers falls -23.6% »

Signet Jewelers is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$27.64

2.27 (8.95%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Skechers rises 9.2% »

Skechers is up 9.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSV

Carriage Services

$18.60

1.61 (9.48%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Carriage Services rises 9.6% »

Carriage Services is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

SNH

Senior Housing

$12.82

-0.07 (-0.54%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Options
Put buyers in Senior Housing Properties »

Put buyers in Senior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.00

(0.00%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Sears confirms ESL selected as winning bidder in bankruptcy auction »

Sears Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OZM

Och-Ziff Capital

$12.51

1.27 (11.30%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Och-Ziff Capital rises 11.1% »

Och-Ziff Capital is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$68.66

0.78 (1.15%)

, PLCE

Children's Place

$87.83

2.66 (3.12%)

11:57
01/17/19
01/17
11:57
01/17/19
11:57
Periodicals
Target revamps its baby line Cloud Island to include essential items, CNBC says »

With the demise of …

TGT

Target

$68.66

0.78 (1.15%)

PLCE

Children's Place

$87.83

2.66 (3.12%)

CRI

Carter's

$78.68

0.48 (0.61%)

GPS

Gap

$25.28

0.38 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

, AMPH

Amphastar

$21.90

0.1 (0.46%)

11:57
01/17/19
01/17
11:57
01/17/19
11:57
Recommendations
Emergent BioSolutions, Amphastar analyst commentary  »

Wells says naloxone news…

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

AMPH

Amphastar

$21.90

0.1 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

, AMPH

Amphastar

$21.91

0.11 (0.50%)

11:55
01/17/19
01/17
11:55
01/17/19
11:55
Hot Stocks
FDA commissioner describes efforts to support development of OTC naloxone »

FDA Commissioner Scott…

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

AMPH

Amphastar

$21.91

0.11 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.